جست‌وجوی استاد و پژوهشگر

James Di Santoمشاهده پروفایل

استاد پژوهشی

• Immunology
• Innate Immunity
• Development of the Immune System
• +۸ مورد دیگر

James Di Santo is a leading researcher and Structure Manager at the Institut Pasteur , where he heads projects within the Innate Immunity Unit (Inserm U1223). He leads a vibrant research group focused on innate lymphoid cells, immune development, and host responses to infectious diseases. His work bridges fundamental immunology and translational applications using advanced mouse models. His research interests span innate immunity , development of the immune system , innate lymphoid cells (ILCs) , mucosal immunity , infectious diseases (including HIV, TB, malaria, and hepatitis), and humanized mouse models . His work explores the molecular and cellular mechanisms underlying immune responses, with implications for vaccinology and anticancer immunity. His recent publications reflect a strong focus on ILC biology, immune signaling (e.g., IL-7, Notch, RORC), host-pathogen interactions (particularly HIV and mycobacteria), and the development of sophisticated animal models. The research trends emphasize mechanistic insights into immune cell differentiation, function, and regulation in health and disease. His scientific awards include the prestigious ERC-2015-AdG ILC_REACTIVITY grant, highlighting the significance and innovation of his work in innate lymphoid cell biology. James Di Santo actively mentors the next generation of scientists, supervising numerous PhD students and postdoctoral fellows . His research is supported by major grants, including ERC funding, enabling cutting-edge projects in immunology and infectious disease modeling. He is a key figure in collaborative initiatives such as the Think tank: Mucosal Immunology. He leads a dedicated research team within the Innate Immunity Unit at the Institut Pasteur, fostering a collaborative environment for studying lymphocyte biology in mice and humans. His laboratory is at the forefront of developing and utilizing humanized mouse models to dissect complex immune responses.

Gérard Eberlمشاهده پروفایل

استاد

• Immunology
• Mucosal Immunity
• Innate Lymphoid Cells (ILCs)
• +۷ مورد دیگر

Gérard Eberl is a Professor and the Structure Manager Responsible at the Institut Pasteur in Paris, leading the research unit on Microenvironment and Immunity. His work is central to understanding the complex interactions between the host immune system, the gut microbiota, and the nervous system. Position: Professor, Structure Manager Responsible Institution: Institut Pasteur Department: Microenvironment and Immunity Contact: gerard.eberl@pasteur.fr His research focuses on the fundamental role of the symbiotic microbiota in host physiology, particularly in the development and regulation of the immune system. He investigates the function of Innate Lymphoid Cells (ILCs) in mucosal defense and tissue homeostasis, and explores the emerging field of neuroimmunology, where he has demonstrated direct communication between gut bacteria, the enteric nervous system, and systemic immune and metabolic responses. His recent publications reveal a strong trend in the intersection of immunology, microbiology, and neuroscience. His work frequently examines how microbial signals are sensed by neurons (e.g., via Nod2) to regulate appetite and inflammation, and how the brain responds to peripheral immune signals (e.g., IL-1β) to modulate systemic physiology. His research program is highly interdisciplinary, bridging mucosal immunology, microbial ecology, and neurobiology. Dr. Eberl has supervised numerous PhD students and post-doctoral fellows, contributing significantly to training the next generation of scientists in the field of immunology and host-microbe interactions. His leadership in major projects like 'Symbiotic microbiota and the development and regulation of the immune system' and 'The role of Intestinal lymphoid cells (ILCs) in defense and physiology' underscores his prominent role in the research community. He is involved in collaborative research environments, including the 'Microbes & Brain' Grand Programme Fédérateur, which brings together international teams in neuroscience and immunology. His work is supported by significant funding from initiatives such as LabEx IBEID and the 'When Gut Bacteria Changes Brain Functions' project.

Prashant Nighotمشاهده پروفایل

استاد

• Intestinal Mucosal Homeostasis
• Tight Junction Barriers
• Autophagy Regulation
• +۴ مورد دیگر

Dr. Prashant Nighot is a Professor and Vice Chair for Research in the Department of Medicine Division of Gastroenterology and Hepatology. His research focuses on intestinal mucosal homeostasis, particularly the role of tight junction (TJ) barriers in inflammatory bowel diseases (IBD). He investigates autophagy's role in TJ regulation, with NIH-funded studies exploring autophagy-mediated TJ enhancement to prevent intestinal inflammation. His lab also examines targets like the AhR pathway and ClC-2 chloride channels to combat IBD. Dr. Nighot teaches graduate courses in Cell System Biology and co-directs the GI Pathophysiology course for medical students. Research Interests: TJ barrier defects in IBD, autophagy mechanisms, AhR pathway activation, ClC-2 chloride channel function. Recent Projects: NIH-funded studies on autophagy-TJ interactions and novel ligands for AhR pathway activation. Publications span 2003–2025, with recent work emphasizing TJ regulation via novel pathways and clinical trials for exercise interventions.

• Metabolism
• Immunology
• Biochemistry
• +۳ مورد دیگر

Vincent de Boer is an Assistant Professor at Wageningen University in the Department of Human and Animal Physiology and holds a WIAS Assistant Professor appointment. His research focuses on metabolism and immunology with expertise in extracellular flux analysis, oxygen consumption, and metabolic pathways using models ranging from cell lines to mice and zebrafish. His research spans metabolic regulation in health and disease, investigating SIRT5 function, mitochondrial fitness, and immune-metabolic crosstalk. Key methodologies include flux analysis of peripheral blood mononuclear cells, protein degradation studies under hypoxia, and development of bioinformatics tools for cellular imaging. Work has implications for understanding intestinal diseases, muscle atrophy, and metabolic disorders. Recent publications (2024-2025) demonstrate strong continuity in metabolic research, featuring SIRT5 neuropathology studies, hypoxia-induced protein catabolism mechanisms, and innovative data analysis tools. The work bridges fundamental biochemistry with physiological applications in aging, immunity, and tissue-specific metabolism. He has co-supervised five PhD students on critical projects: Interleukin-22 in zebrafish intestinal health and disease Protein fermentation impacts on pig intestinal barrier function Dietary approaches to improve innate immune health White adipose tissue adaptive capacity mechanisms Pseudo-hypoxia targeting for muscle mitochondrial fitness in aging Research is supported through multiple active and completed projects investigating metabolic health optimization through diet, mitochondrial function, and tissue-specific adaptations, with strong institutional backing from Wageningen University & Research.

• Immunology
• Gastroenterology
• Inflammatory Bowel Disease (IBD)
• +۷ مورد دیگر

David Elliott, MD, PhD, is a Professor of Internal Medicine in the Division of Gastroenterology and Hepatology at the Carver College of Medicine, University of Iowa. He also serves as the Director of the Division of Gastroenterology and Hepatology, leading clinical and research initiatives in gastrointestinal diseases and immunology. PhD in Immunology, Wayne State University, Detroit, MI MD, Wayne State University, Detroit, MI Residency in Internal Medicine, Johns Hopkins Hospital, Baltimore, MD Fellowship in Gastroenterology, University of Iowa, Iowa City, IA Dr. Elliott’s research centers on the immunological basis of inflammatory bowel diseases (IBD), with a focus on how parasitic helminths modulate the immune system to suppress inflammation. His work explores the role of T-cell signaling pathways such as Stat6 and TGF-β in colitis and graft-versus-host disease (GVHD), aiming to develop novel immunomodulatory therapies. He investigates the interplay between gut immunity and systemic inflammation, including the gut-lung axis and post-transplant immune responses. His recent publications reveal a strong trend in using helminth-based models to understand immune regulation in colitis, GVHD, and autoimmune conditions. These studies employ murine models and molecular techniques to dissect cytokine signaling, epithelial barrier integrity, and the therapeutic potential of parasite-derived immunomodulation. His work bridges basic immunology and clinical gastroenterology, contributing to both mechanistic understanding and translational applications. Dr. Elliott is certified by the American Board of Internal Medicine in Internal Medicine and Gastroenterology and holds a medical license in Iowa. He is actively engaged in clinical care, research, and academic leadership. Notable scientific contributions include: Investigating helminth-induced immune tolerance in IBD Elucidating the role of Stat6 and furin in TGF-β production by T cells Exploring the preservation of graft-versus-tumor effects during helminth-mediated GVHD suppression Contributing to clinical trials on infliximab for Crohn’s disease recurrence Dr. Elliott mentors junior researchers and collaborates extensively within the University of Iowa and nationally. While formal advisees are not listed, his leadership in research groups and publications with trainees indicates active involvement in academic training. He has not received publicly listed awards in the provided text, but his sustained publication record and divisional leadership reflect significant scholarly impact. His work is supported by institutional and potentially federal research funding, though specific grants are not detailed. He is affiliated with the Program in Bioinformatics and Computational Biology and contributes to interdisciplinary research efforts. His laboratory likely focuses on mucosal immunology, using transgenic mouse models and cellular immunology techniques to study intestinal inflammation and immune regulation.

Cyril Seilletمشاهده پروفایل

دانشیار

• Mucosal Immunology
• Innate Immunity
• Neuroimmunology
• +۹ مورد دیگر

Cyril Seillet is an Associate Professor in the Department of Immunology at Monash University, where he leads the Integrated Mucosal Immunity (IMI) Laboratory. He is also affiliated with the Alfred Hospital and is an NHMRC Emerging Leadership Fellow. His research bridges immunology, neuroscience, and metabolism, focusing on how physiological cues regulate immune function at barrier sites. Research Interests: Mucosal Immunology and Tissue Homeostasis: Investigates immune cell roles in gut and lung barrier integrity, host-microbe balance, and diseases like IBD and asthma. Neuroimmune Interactions: Explores how sympathetic and sensory neurons communicate with immune cells using chemogenetic and biosensing tools to regulate inflammation. Physiological Regulation of Immunity: Studies how dietary lipids, circadian rhythms, hormones, and metabolites reprogram immune metabolism to maintain balance and combat chronic inflammation. His recent publications (2020–2025) highlight a strong focus on innate lymphoid cells (ILCs), neuropeptides (e.g., VIP), circadian control, and transcriptional regulation in mucosal and lung immunity. These works, published in Nature Immunology and Science Immunology , reveal novel mechanisms linking neural and metabolic signals to immune function, offering therapeutic avenues for inflammatory diseases. Scientific Awards: Burnet Prize for outstanding discovery research (2020) NHMRC R.D. Wright Biomedical Career Development Fellowship (2016) NHMRC Emerging Leadership Fellow Dr Seillet is actively involved in research leadership and supervision, currently accepting PhD and honors students. He is the Primary Chief Investigator on the NHMRC-funded project Circadian Control of Innate Immunity: Strategies for Treatment of Chronic Diseases (2022–2026). His lab fosters interdisciplinary collaboration at the interface of immunology, metabolism, and neuroscience. He is affiliated with research efforts contributing to UN Sustainable Development Goals related to health and well-being. Laboratory: Integrated Mucosal Immunity (IMI) Laboratory at Monash University.

Randy Mrsnyمشاهده پروفایل

استاد

• Epithelial Cell Biology
• Drug Delivery
• Biotherapeutics
• +۷ مورد دیگر

Randy Mrsny is a Professor in the Department of Life Sciences at the University of Bath, where he leads the Mrsny Laboratory within the Centre for Therapeutic Innovation. His work bridges academic research and industrial pharmaceutical development, with a strong focus on epithelial biology and advanced drug delivery systems. His research interests center on epithelial cell structure and function in health and disease, particularly: Identification of epithelial-secreted molecules regulating immune cell transmigration (neutrophils, eosinophils) Mechanisms of lymphocyte activation control by epithelial cells Role of tight junctions in epithelial oncogenesis and dynamic regulation for drug delivery Exploitation of bacterial toxin transcytosis pathways for delivering biotherapeutics (proteins, peptides, siRNA) His recent publications reflect a strong trend in developing innovative in vitro models for drug delivery, particularly focusing on subcutaneous and intramuscular injection sites using biomimetic hydrogels. His work integrates pharmaceutical sciences, cell biology, and biomaterials to improve the delivery and efficacy of biopharmaceuticals. Key themes include tight junction modulation, toxin-based delivery systems, and formulation science for sustained release. Randy Mrsny has led multiple externally funded projects from agencies such as the MRC and BBSRC, including initiatives on peptide synthesis platforms, light sheet microscopy, and enhanced oral delivery of biopharmaceuticals. He has also participated in Knowledge Transfer Partnerships with industry, demonstrating strong translational impact. He has supervised 11 research students and early-career researchers. His laboratory collaborates extensively with pharmaceutical companies and international agencies, and he serves as an advisor and reviewer for multiple organizations. The Mrsny Lab contributes to UN Sustainable Development Goals related to good health and well-being through its focus on therapeutic innovation.

Nicola Harrisمشاهده پروفایل

استاد

• Mucosal Immunology
• Host-Microbe Interactions
• Inflammatory Bowel Disease
• +۱۱ مورد دیگر

Nicola Harris is a Professor in the Department of Immunology at Monash University's Faculty of Medicine, Nursing and Health Sciences, and is affiliated with the Alfred Hospital. She co-leads the Mucosal Immunology Research Group and is an NHMRC Senior Research Fellow. Her research focuses on understanding the immunological, microbiological, and physiological mechanisms of mucosal health and disease in the gastrointestinal tract and airways. Research Interests: Her work spans Mucosal Immunology , Host-Microbe Interactions , Inflammatory Bowel Disease (IBD) , Lung Fibrosis , and Neuro-Immune Crosstalk . She investigates how diet, the microbiome, and metabolites influence immune responses, aiming to develop science-driven nutritional therapies for IBD and strategies to halt progressive lung fibrosis. Her research also explores the gut-lung axis and the role of type 2 immunity in tissue repair and metabolism. Recent Research Trends: Analysis of her recent publications reveals a strong focus on the interplay between the microbiome and immunity, particularly how microbial metabolites (e.g., indole-3-propionic acid, short-chain fatty acids) modulate allergic and inflammatory diseases. She utilizes both preclinical models and human tissue studies, with increasing emphasis on neuro-immune interactions in chronic diseases of the gut and lung. Scientific Awards: ERC Starting Grant (2012) Leenards Prize (2021) Cancer Research Institute Postdoctoral Fellowship Human Frontier Science Program Long Term Fellowship FRST New Zealand Postdoctoral Fellowship Grants and Supervision: Professor Harris has led multiple competitive research grants, including an NHMRC Project Grant on Type 2 immunity and metabolism (2018–2023). She is actively accepting PhD and honors students, with current projects focusing on dietary therapies for IBD and immune-neural crosstalk in chronic lung disease. Laboratory and Team: She co-leads the Mucosal Immunology Research Group at Monash, which investigates the mechanisms of mucosal immunity and disease, integrating immunology, microbiology, and physiology to develop novel therapeutic approaches.

Anastasia Sobolewskiمشاهده پروفایل

مدرس

• Pharmacology
• Mucosal Immunology
• Cancer Biology
• +۸ مورد دیگر

Anastasia Sobolewski is a Lecturer in Pharmacology at the University of East Anglia, affiliated with the School of Chemistry, Pharmacy and Pharmacology and the Molecular and Tissue Pharmacology research group. She is actively accepting PhD students and leads a research program focused on mucosal tissue in the lung and gut. Education: B.Sc. (Hons) in Pharmacology, University of Sunderland (1998) Ph.D. in Cell Biology and Cell Physiology, University of East Anglia (2002) Her research centers on mucosal immunology, epithelial stem cells, and intercellular communication in health, inflammation, and cancer. She employs 3D organoid models, bio-imaging, and molecular techniques to study lung cancer resistance mechanisms and gut barrier regulation. Key topics include tunnelling nanotubes in chemoresistance and immune-epithelial crosstalk in intestinal homeostasis. Her recent publications show a strong trend in cancer signaling, macrophage biology, and chemical probe development, reflecting an interdisciplinary approach bridging pharmacology, immunology, and cell biology. Scientific Awards: No specific awards mentioned in the text. Anastasia Sobolewski supervises multiple PhD and MSc students and has secured research funding from the Wellcome Trust and the Engineering and Physical Sciences Research Council. She is involved in interdisciplinary projects, including one on Raman microscopy and another on brain stem cell function funded by the Royal Embassy of Saudi Arabia. Her lab functions as an active research team focusing on mucosal tissue dynamics.

• Mucosal Immunology
• Gut Biology
• Inflammatory Bowel Disease (IBD)
• +۱۴ مورد دیگر

Simon Carding is a Professor of Mucosal Immunology at Norwich Medical School, University of East Anglia (UEA), and a Research Leader in the Gut Health and Food Safety (GHFS) Programme at the Institute of Food Research. He is also a member of the Norwich Institute for Healthy Aging. His work integrates mucosal immunology, gut microbiology, and host-microbe interactions to understand intestinal health and disease. PhD, MRC Clinical Research Centre, Harrow (1985) Visiting Instructor, NYU School of Medicine (1985–1986) Postdoctoral Associate & Howard Hughes Fellow, Yale University (1986–1991) Assistant/Associate Professor, University of Pennsylvania (1991–1999) Professor of Molecular Immunology, University of Leeds (1999–2008) Professor of Mucosal Immunology, UEA (2008–present) His research centers on mucosal immunology, intestinal microbial tolerance, and the role of host-microbe crosstalk in health and diseases like inflammatory bowel disease (IBD). He investigates autophagy, epithelial barrier function, dendritic cell biology, and the development of engineered Bacteroides for therapeutic delivery. His group also explores immunosenescence, chronic fatigue syndrome, and gut-brain axis interactions. The recent publications highlight a strong trend in bacterial extracellular vesicles, engineered probiotics, gut-brain translocation models, and functional assessment in chronic fatigue. His work often involves interdisciplinary approaches combining immunology, microbiology, bioengineering, and computational modeling. RCUK Grant Review and Advisory Panels (2000–) Grant reviewer for international funding bodies (2008–) Advisory boards for biomedical charities and industry (2000–) Invited speaker at national and international conferences (1990–) Reviewer for international journals (1986–) Simon Carding has supervised postgraduate research students in gut biology, mucosal immunity, and microbiome-related fields. He has secured grants from BBSRC, Innovate UK, and Invest in ME, including projects on viral phagocytosis, chronic fatigue, and bacterial vesicle vaccines. He founded Ovatus Ltd., a spin-out company with UK and international patents, demonstrating strong enterprise engagement. He leads the GHFS Programme, comprising 13 research groups and around 60 scientists, focusing on gut epithelial physiology, microbiome, immunity, and food safety. The programme integrates experimental and computational approaches to advance gut health research.

Rebecca Carrierمشاهده پروفایل

دانشیار

• Mucosal Drug Delivery
• Intestinal Barrier Function
• Bioengineering
• +۴ مورد دیگر

Rebecca Carrier is an Associate Professor of Chemical Engineering at Northeastern University, specializing in mucosal drug delivery and intestinal barrier function. Her work focuses on engineering biomimetic systems to study drug-mucus interactions, microbial dynamics, and gut physiology. She pioneered the development of gut-on-a-chip models to simulate human intestinal environments and has received a $1.8 million NIH grant to investigate lipid roles in drug absorption. Her research bridges chemical engineering, biomedical sciences, and pharmaceutical technologies. Education: Advanced degrees in chemical engineering and biomaterials science (details not specified). Labs/Teams: Leads Northeastern's gut microphysiological systems initiative, collaborating with pharmaceutical and biotechnology partners. Her research interests include optimizing drug delivery systems using mucus-mimetic materials and understanding how dietary lipids modulate gut barrier properties. She explores hydrogen sulfide's role in gut health and develops biosensors for anaerobic microenvironments. Carrier's organ-on-a-chip platforms enable study of Crohn's disease and microbial-host interactions, offering preclinical models for drug efficacy and toxicity testing. Recent studies highlight mucus's role in stabilizing drug supersaturation and its implications for oral formulations. She advocates for biorelevant in vitro models to predict drug behavior in physiological conditions. Carrier's interdisciplinary approach integrates microfluidics, polymer chemistry, and synthetic biology to address challenges in gastrointestinal health and drug delivery. Grant funding supports her work on lipid-enhanced drug absorption and mucosal barrier strengthening. She mentors graduate students in bioengineering and collaborates on projects like engineered bacteria for hydrogen sulfide regulation. Carrier's lab also develops decellularized extracellular matrix scaffolds for retinal regeneration studies, showcasing her broader impact in regenerative medicine.

Katharina Maiselمشاهده پروفایل

استادیار

• Mucosal Drug Delivery
• Immunoengineering
• Lymphatic Pathophysiology
• +۳ مورد دیگر

Katharina Maisel is an Assistant Professor in the Fischell Department of Bioengineering at the University of Maryland, College Park. Her research focuses on mucosal drug delivery, immunoengineering, and lymphatic pathophysiology. She leads the Mucosal Associated Immune System Engineering and Lymphatics Lab, which designs in vitro models and nanotechnology-based solutions to study and treat mucosal diseases. Her work bridges bioengineering, immunology, and nanotechnology, with emphasis on understanding stromal-lymphatic interactions in disease contexts. Research interests include developing therapeutic strategies targeting the lymphatic system, in vitro platforms for disease modeling, and understanding how inflammation alters tissue properties. Her lab’s innovative approaches involve microfluidic systems and nanoparticle design to enhance drug delivery efficacy. Current projects explore mucosal immunity, vaccine development, and the role of lymphatic vessels in allergic asthma and emphysema. Recent publications highlight advancements in lymphatic transport mechanisms, hypotonic drug delivery systems, and the biomechanical roles of lymph nodes in immunity. Her team is actively engaged in promoting equitable hiring practices in academia and fostering inclusive research environments. The lab collaborates with industry and sponsors to translate fundamental discoveries into clinical applications.

Waliul Khanمشاهده پروفایل

استاد

• Gastroenterology
• Immunology
• Microbiology
• +۵ مورد دیگر

Dr. Waliul Khan is a Professor in the Department of Pathology & Molecular Medicine at McMaster University's Faculty of Health Sciences. He leads a research laboratory situated within the Farncombe Family Digestive Health Research Institute, focusing on gastrointestinal health and its complex interplay with intestinal serotonin, microbiota, autophagy, and host defense mechanisms. His research interests span Gastroenterology, Immunology, Microbiology, and Parasitology, with a specific focus on inflammatory bowel disease (IBD), host-pathogen interactions, and intestinal immune responses. Dr. Khan's work has established critical connections between gut-derived serotonin, immune function, and microbiome composition, revealing novel pathways in intestinal inflammation and host defense. Analysis of Dr. Khan's recent publications reveals a strong trend toward understanding the role of serotonin signaling in gut health, particularly its impact on immune responses, microbiome composition, and barrier function. His research has expanded into examining how food additives influence gut health, how probiotics like Akkermansia muciniphila modulate inflammation, and how circadian rhythms affect intestinal inflammation. Picked up by 109 news outlets for research on food dyes and IBD Featured in Nature Communications for work on Allura Red and colitis Extensive media coverage for serotonin research Highly cited publications with up to 735 Mendeley readers Research referenced in multiple Wikipedia pages and patents Dr. Khan teaches Integrated Systems in Gastrointestinal Health and Disease I (MEDSCI 713) and Clinical Biochemistry (BIOCHEM 3H03) at McMaster University. His laboratory investigates the mechanisms underlying gastrointestinal disorders, with the goal of developing improved diagnostic strategies and therapeutic interventions for conditions like inflammatory bowel disease.

Hongbing Yuمشاهده پروفایل

استادیار

• Infectious Diseases
• Immunology
• Microbiology
• +۶ مورد دیگر

Hongbing Yu, Ph.D. is an Assistant Professor in the Department of Microbiology, Molecular Genetics and Immunology at the University of Kansas School of Medicine. His research focuses on the molecular and cellular mechanisms involved in infectious and immune diseases, with particular emphasis on host-microbe interactions at the intestinal barrier. Dr. Yu's research interests center on understanding how host-microbe interactions occur at the intestinal barrier. His work has made significant contributions to the field through the discovery of a key neuroimmune axis whereby the recruitment of group 3 innate lymphoid cells (ILC3s) in the intestine is controlled by the neuropeptide vasoactive intestinal peptide (VIP). He has also revealed important mechanisms by which serine protease autotransporters of Enterobacteriaceae (SPATEs) contribute to intestinal colonization and pathogenesis, particularly in Citrobacter rodentium infections. Analysis of Dr. Yu's recent publications (2020-2025) reveals a strong focus on intestinal barrier function, host-pathogen interactions, and inflammatory bowel disease mechanisms. His work frequently employs advanced techniques including organoid models, flow cytometry-based permeability measurements, and molecular approaches to dissect signaling pathways involved in mucosal immunity. Key themes include neuroimmune regulation, bacterial virulence mechanisms, mucosal defense systems, and the development of therapeutic approaches for gastrointestinal disorders. Dr. Yu maintains active collaborations with prominent researchers in the field, particularly Bruce Vallance and Kevan Jacobson, as evidenced by his extensive publication record. His research bridges basic science with potential clinical applications, particularly in understanding and treating inflammatory bowel diseases and infectious diarrheal diseases.

• Gastroenterology
• Hepatology
• Colon Cancer
• +۷ مورد دیگر

Jean-Pierre Raufman is a Professor in the Department of Medicine at the University of Maryland. He serves as Division Head of Gastroenterology & Hepatology and leads research on gastrointestinal signaling in colon cancer. Albert Einstein College of Medicine (MD) Postdoctoral training: University of Michigan, NIH His research focuses on muscarinic receptor signaling, bile acid interactions, and molecular mechanisms in gastrointestinal neoplasia. He explores roles of βPix, MMP1, and microbiome in cancer progression. Recent articles highlight microbiome variability in IBD, bile acid transport, and muscarinic receptor subtypes in cancer. Trends include extracellular vesicles, metabolomics, and immune-microbe interactions. American Society for Clinical Investigation - Elected Member Dr. Raufman has secured NIH R01, T32, and VA Merit grants. He directs the GI and Liver Scholars Fellowship Program and collaborates with the Greenebaum Cancer Center.